Portal de Periódicos da CAPES

Bisphosphonate Therapy for Hormone Refractory Prostate Cancer with Bone Metastasis

2003; Lippincott Williams & Wilkins; Volume: 169; Issue: 1 Linguagem: Inglês

10.1016/s0022-5347(05)64093-1

1527-3792

Hideki Asahi, A. Mizokami, Yuji Maeda, Kazuto Komatsu, Kiyoshi Koshida, Mikio Namiki,

Radiopharmaceutical Chemistry and Applications

No AccessJournal of UrologyCLINICAL UROLOGY: Case Reports1 Jan 2003Bisphosphonate Therapy for Hormone Refractory Prostate Cancer with Bone Metastasisis corrected byErrata HIDEKI ASAHI, ATUSHI MIZOKAMI, YUJI MAEDA, KAZUTO KOMATSU, KIYOSHI KOSHIDA, and MIKIO NAMIKI HIDEKI ASAHIHIDEKI ASAHI More articles by this author , ATUSHI MIZOKAMIATUSHI MIZOKAMI More articles by this author , YUJI MAEDAYUJI MAEDA More articles by this author , KAZUTO KOMATSUKAZUTO KOMATSU More articles by this author , KIYOSHI KOSHIDAKIYOSHI KOSHIDA More articles by this author , and MIKIO NAMIKIMIKIO NAMIKI More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64093-1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Bisphosphonate Therapy for Hormone Refractory Prostate Cancer with Bone Metastasis." The Journal of Urology, 169(1), pp. 281–282 References 1 : The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. J Urol2001; 165: 136. Link, Google Scholar 2 : Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res2001; 61: 2602. Google Scholar 3 : The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells. Br J Cancer2002; 86: 1479. Google Scholar From Yatsuo General Hospital, Toyama, Japan© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyNov 9, 2018, 9:50:33 AMErrata Volume 169Issue 1January 2003Page: 281-282 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.Keywordsbone neoplasmsclodronic acidneoplasm metastasisdiphosphonatesprostatic neoplasmsMetricsAuthor Information HIDEKI ASAHI More articles by this author ATUSHI MIZOKAMI More articles by this author YUJI MAEDA More articles by this author KAZUTO KOMATSU More articles by this author KIYOSHI KOSHIDA More articles by this author MIKIO NAMIKI More articles by this author Expand All Advertisement PDF DownloadLoading ...